Overexpression of LIF in breast cancer and colorectal cancer cells promotes cancer cells to acquire mesenchymal features, increase the expression of mesenchymal markers, including Vimentin and N-cadherin, and decrease the expression of E-cadherin. Here, CDH2 is linked to breast cancer.